Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating a combination of gemcitabine, nab-paclitaxel, and bosentan for unresectable pancreatic cancer is current…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer [Phase 3]
Phase 3 clinical trial evaluating the effectiveness and safety of Setidegrasib in combination with either modified FOLFIRINOX (mFOLFIRINOX) …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer [Phase 2]
A Phase II trial evaluating BMS-986504 in MTAP-deleted pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer. [Phase 1]
Phase 1b trial evaluating the combination of gemcitabine, nab-paclitaxel, and IM156 in patients with advanced pancreatic cancer; the study i…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A clinical trial update for ANO-31905 in combination with chemotherapy for CLDN18.2-positive pancreatic cancer, listed as Phase 1/2 and not …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer [Phase 2]
Phase II clinical trial evaluating HRS-4642 in combination with nab-paclitaxel and gemcitabine as conversion therapy for locally advanced pa…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer [Phase 1, Phase 2]
This is a phase 1/2 clinical trial evaluating a KRAS neoantigen nanovaccine as adjuvant therapy for colorectal cancer and pancreatic cancer,…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients [Phase 1]
Phase 1 trial evaluating 18F-Fluoroazomycin Arabinoside PET-CT for diagnosing solid tumors, including breast and colorectal cancers, with ac…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors [NA]
This clinical trial update describes Total Pancreatectomy with Islet Autotransplantation (TPIAT) for high-risk pancreatic tumor patients; th…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients [Phase 2]
This clinical trial update describes a phase 2 study comparing Gembrax followed by FOLFIRINOX versus FOLFIRINOX alone in patients with metas…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer [Phase 1]
Phase 1 pilot study evaluating the clinical utility of Pylarify PET-CT for detecting metastasis in pancreatic cancer, hepatocellular carcino…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial [Phase 3]
An ongoing randomized Phase III trial (EXPAND) is evaluating outcomes for pancreatic cancer patients with nominal oligometastatic disease; t…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments [Phase 1, Phase 2]
The document reports a Phase 1/2 clinical trial of XNW28012 for advanced solid tumors, including pancreatic cancer, with recruiting ongoing.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study [NA]
This clinical trial update describes the PancStrength study, which investigates resistance training to improve physical function in patients…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
A trial update describing the development and validation plan for an epigenetic assay intended to diagnose pancreatic cancer; the study is n…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6 [Phase 1]
This is a Phase 1 clinical trial evaluating different doses of BI 765049 alone and in combination with Ezabenlimab in Asian patients with ad…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening [NA]
This clinical trial update describes a study evaluating intermittent fasting in individuals at high risk for pancreatic cancer undergoing sc…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
A clinical trial examining whether chronic psychological stress affects the course of pancreatic cancer is listed. The study is currently no…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial [Phase 2]
A Phase 2 ComboMATCH trial evaluates the combination of palbociclib and binimetinib in RAS-mutant cancers, including pancreatic and ovarian …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations [Phase 2]
Phase 2 study evaluating adding pembrolizumab to olaparib for metastatic pancreatic cancer with BRCA mutations.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
This clinical trial update describes a pancreatic cancer screening study in individuals with hereditary high risk, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study of LY4101174 in participants with recurrent, advanced or metastatic solid tumors is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
A clinical trial update describes a study evaluating microRNA as a diagnostic, prognostic, and treatment-response biomarker in pancreatic ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial evaluating adding Peposertib (M3814) to radiotherapy for locally advanced pancreatic cancer is currently recruiting (Phase 1/…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer [Phase 1]
A Phase 1 trial is evaluating the safety of combining durvalumab and olaparib with radiation therapy in locally advanced unresectable pancre…